Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,063

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Open access
Ni, Ling, Ye, Fang, Cheng, Meng-Li, Feng, Yu, Deng, Yong-Qiang, Zhao, Hui, Wei, Peng, Ge, Jiwan, Gou, Mengting, Li, Xiaoli, Sun, Lin, Cao, Tianshu, Wang, Pengzhi, Zhou, Chao, Zhang, Rongrong, Liang, Peng, Guo, Han, Wang, Xinquan, Qin, Cheng-Feng, Chen, Fang, Dong, Chen·2020·Immunity

Abstract

Summary The World Health Organization has declared SARS-CoV-2 virus outbreak a worldwide pandemic. However, there is very limited understanding on the immune responses, especially adaptive immune responses to SARS-CoV-2 infection. Here, we collected blood from COVID-19 patients who have recently become virus-free, and therefore were discharged, and detected SARS-CoV-2-specific humoral and cellular immunity in eight newly discharged patients. Follow-up analysis on another cohort of six patients 2 weeks post discharge also revealed high titers of immunoglobulin G (IgG) antibodies. In all 14 patients tested, 13 displayed serum-neutralizing activities in a pseudotype entry assay. Notably, there was a strong correlation between neutralization antibody titers and the numbers of virus-specific T cells. Our work provides a basis for further analysis of protective immunity to SARS-CoV-2, and understanding the pathogenesis of COVID-19, especially in the severe cases. It also has implications in developing an effective vaccine to SARS-CoV-2 infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2020.04.023

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 17

  1. Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 395, 514, 10.1016/S0140-6736(20)30154-9 · DOI · Paper page
  2. Deng, 1997, Expression cloning of new receptors used by simian and human immunodeficiency viruses, Nature, 388, 296, 10.1038/40894 · DOI · Paper page
  3. Di Pierro, 2020, Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus, Minerva Gastroenterol. Dietol., 10.23736/S1121-421X.20.02697-5 · DOI
  4. Haveri, 2020, Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020, Euro Surveill., 25, 16, 10.2807/1560-7917.ES.2020.25.11.2000266 · DOI · Paper page
  5. Ko, 2017, Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity, Diagn. Microbiol. Infect. Dis., 89, 106, 10.1016/j.diagmicrobio.2017.07.006 · DOI
  6. Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8 · DOI · Paper page
  7. Mahallawi, 2018, MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile, Cytokine, 104, 8, 10.1016/j.cyto.2018.01.025 · DOI · Paper page
  8. Nicholls, 2003, Lung pathology of fatal severe acute respiratory syndrome, Lancet, 361, 1773, 10.1016/S0140-6736(03)13413-7 · DOI · Paper page
  9. Shi, 2004, Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients, J. Clin. Virol., 31, 66, 10.1016/j.jcv.2004.05.006 · DOI
  10. Thevarajan, 2020, Breadth of Concomitant Immune Responses Prior to Patient Recovery: A Case Report of Non-Severe COVID-19, Nat. Med., 26, 453, 10.1038/s41591-020-0819-2 · DOI · Paper page
  11. Thiel, 2008, Interferon and cytokine responses to SARS-coronavirus infection, Cytokine Growth Factor Rev., 19, 121, 10.1016/j.cytogfr.2008.01.001 · DOI
  12. Vijay, 2016, Middle East respiratory syndrome and severe acute respiratory syndrome, Curr. Opin. Virol., 16, 70, 10.1016/j.coviro.2016.01.011 · DOI
  13. Wang, 2016, Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China, Emerg. Microbes Infect., 5, e113, 10.1038/emi.2016.114 · DOI · Paper page
  14. Wang, 2020, A novel coronavirus outbreak of global health concern, Lancet, 395, 470, 10.1016/S0140-6736(20)30185-9 · DOI · Paper page
  15. Woo, 2004, Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia, J. Clin. Microbiol., 42, 2306, 10.1128/JCM.42.5.2306-2309.2004 · DOI
  16. Xie, 2018, Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors, Cancer Immunol. Immunother., 67, 1685, 10.1007/s00262-018-2227-8 · DOI
  17. Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page

Cited by

See all 1,063

Metadata

Authors
Ni, L., Ye, F., Cheng, M.-L., Feng, Y., Deng, Y.-Q., Zhao, H., Wei, P., Ge, J., Gou, M., Li, X., Sun, L., Cao, T., Wang, P., Zhou, C., Zhang, R., Liang, P., Guo, H., Wang, X., Qin, C.-F., Chen, F., & Dong, C.
Venue
Immunity
Publisher
Elsevier BV
Published
2020-06
Volume
52
Issue
6
Pages
971-977.e3
ISSN
1074-7613 (ISSN-L)
OpenAlex
W3021544284
Cited by
1,063
References
7
FWCI
29.51
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Zhejiang University (2020XGZX014)
  • National Natural Science Foundation of China (31991173, 31991170, 31821003)
  • Beijing Municipal Science and Technology Commission (Z181100001318007, Z171100000417005, Z181100006318015)
  • Tsinghua University
  • Ministry of Science and Technology
  • National Key Research and Development Program of China (2020YFA0707800, 2016YFC130390, 2016YFC0906200)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. https://app.cochat.ai/papers/10.1016/j.immuni.2020.04.023
The paper
Ni, L., Ye, F., Cheng, M.-L., Feng, Y., Deng, Y.-Q., Zhao, H., Wei, P., Ge, J., Gou, M., Li, X., Sun, L., Cao, T., Wang, P., Zhou, C., Zhang, R., Liang, P., Guo, H., Wang, X., Qin, C.-F., . . . Dong, C. (2020). Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity. https://doi.org/10.1016/j.immuni.2020.04.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.